Key result
Higher levels of soluble TNF-alpha receptor II were associated with an increased risk of total coronary heart disease among women with type 2 diabetes.
Why the study?
Do higher levels of soluble TNF-alpha receptor II (sTNF-RII) increase the risk of coronary heart disease in women with type 2 diabetes?
Cohort (n=929)
Do higher levels of soluble TNF-alpha receptor II (sTNF-RII) increase the risk of coronary heart disease in women with type 2 diabetes?
Increased levels of sTNF-RII are strongly associated with an increased risk of coronary heart disease among diabetic women, independent of hyperglycemia.
Answers are grounded in this paper and cite their sources.
Should not yet change CHD risk assessment in T2D women; hypothesis-generating for sTNF-RII as an inflammatory biomarker.
OBJECTIVE: Tumor necrosis factor-alpha (TNF-alpha), a cytokine secreted by adipose tissue and other cells, might play a role in insulin resistance. RESEARCH DESIGN AND METHODS: Of 32,826 women from the Nurses' Health Study who provided blood at baseline, we followed 929 women with type 2 diabetes. During 10 years of follow-up, we documented 124 incident cases of coronary heart disease (CHD). RESULTS: After adjustment for age, smoking, BMI, and other cardiovascular risk factors, the relative risks (RRs) comparing extreme quartiles of soluble TNF-alpha receptor II (sTNF-RII) were 2.48 (95% CI 1.08-5.69; P = 0.034) for myocardial infarction (MI) and 2.02 (1.17-3.48; P = 0.003) for total CHD. The probability of developing CHD over 10 years was higher among diabetic subjects with substantially higher levels of both sTNF-RII (>75th percentile) and HbA(1c) (>7%), compared with diabetic subjects with lower levels (25% vs. 7%, P < 0.0001). Diabetic subjects with only higher sTNF-RII or HbA(1c) had similar (16-17%) risk. In a multivariate model, diabetic subjects with higher levels of both sTNF-RII and HbA(1c) had an RR of 3.66 (1.85-7.22) for MI and 3.03 (1.82-5.05) for total CHD, compared with those with lower levels of both biomarkers. CONCLUSIONS: Increased levels of sTNF-RII were strongly associated with risk of CHD among diabetic women, independent of hyperglycemia.
No takes yet. Share an insight, caveat, or question.
Shai et al. (2005) conducted a cohort in Type 2 diabetes (n=929). Soluble tumor necrosis factor-alpha receptor II (sTNF-RII) vs. Lowest quartile of sTNF-RII was evaluated on Total coronary heart disease (CHD) (RR 2.02, 95% CI 1.17-3.48, p=0.003). Higher levels of soluble TNF-alpha receptor II were associated with an increased risk of total coronary heart disease among women with type 2 diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: